References
- Stern R S. Risks of cancer associated with long-term exposure to PUVA in humans: current status 1991. Blood Cells. Springer-Verlag, New York 1992; 91–9
- Waldow S M, Lobraico R V, Kohler I K., et al. Photodynamic therapy for treatment of malignant cutaneous lesions. Lasers Surg Med 1987; 7: 451–6
- Wolf P, Rieger E, Kerl H. Topical photodynamic therapy with endogenous porphyrins after application of 5-aminolevulinic acid. J Am Acad Dermatol 1993; 28: 17–21
- Lui H, Anderson R. Photodynamic therapy in dermatology: recent developments. Dermatol Clin 1993; 11: 1–13
- Boehncke W H, Sterry W, Kaufmann R. Treatment of psoriasis by topical photodynamic therapy with polychromatic light. Lancet 1994; 343: 801
- Cincotta L, Foley I W, MacEachern T, et al. Novel photodynamic effects of a benzophenothiazine on two different murine sarcomas. Cancer Res 1994; 54: 1249–58
- Orth K, Ruk A, Stanescu A, et al. Intraluminal treatment of inoperable oesophageal tumours by intralesional photodynamic therapy with methylene blue. Lancet 1995; 345: 519–20
- Ruck A, Kollner T, Dietrich A, et al. Fluorescence formation during photodynamic therapy in the nucleus of cells incubated with cationic and anionic water-soluble photosensitizers. J Photochem Photobiol B 1992; 12: 403–12
- Sziemies R M, Heine A, Baumler W, et al. PDT 1200 - a novel incoherent light source for photodynamic treatment of superficial skin lesions. Lasermedizin 1993; 7: 234–8
- Kennedy J C, Pottier R H, Pross D C. Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. J Photochem Photobiol B 1990; 6: 143–8
- Boehncke W H, Konig K, Kaufmann R, et al. Photodynamic therapy in psoriasis: suppression of cytokine production in vitro and recording of fluorescence modification during treatment in vivo. Arch Dermatol Res 1994; 286: 300–3
- Schick E, Kaufmann R, Ruck A, et al. Influence of activation and differentiation of cells on the effectiveness of photodynamic therapy. Acta Derm Venereol 1995; 75: 276–9